TapImmune Announces Phase 2 Ovarian Cancer Trial Study with AstraZeneca/MedImmune & Sloan Kettering Cancer Institute Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Friday, April 22, 2016

TapImmune Announces Phase 2 Ovarian Cancer Trial Study with AstraZeneca/MedImmune & Sloan Kettering Cancer Institute



press release

0 comments :

Post a Comment

Your comments?